{
  "id": "6026ef311cb411341a0000d4",
  "type": "factoid",
  "question": "Which company developed eptinezumab?",
  "ideal_answer": "Eptinezumab was developed by Lundbeck Seattle BioPharmaceuticals.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/32266704"
  ],
  "snippets": [
    {
      "text": "Eptinezumab, delivered by intravenous (IV) administration, is being developed by Lundbeck Seattle BioPharmaceuticals for the prevention of migraine.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32266704",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Lundbeck Seattle BioPharmaceuticals"
}